Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
XRP Surges 3.5% as Ripple Releases Its 2026 Plan, What’s Next for Price?

XRP Surges 3.5% as Ripple Releases Its 2026 Plan, What’s Next for Price?

CoinspeakerCoinspeaker2025/11/05 16:00
By:By Parth Dubey Editor Julia Sakovich

XRP has jumped 3.5% following Ripple’s 2025 Swell event, where executives outlined an ambitious roadmap for 2026.

Key Notes

  • XRP is now trading at $2.29, gaining $4.5 billion in market cap in the past day.
  • Ripple unveiled its 2026 roadmap with focus on infrastructure, regulation, and institutional growth.
  • Analysts see potential rally toward new yearly highs, but warn of resistance near $2.55.

After dipping to a monthly low of $2.09 on Nov. 5, XRP XRP $2.29 24h volatility: 1.7% Market cap: $137.39 B Vol. 24h: $5.53 B has regained momentum, now trading around $2.29, up 3.5% in 24 hours. The rise follows the conclusion of Ripple’s 2025 Swell conference, where CEO Brad Garlinghouse detailed the company’s vision for 2026.

During the event’s closing fireside chat, Garlinghouse noted Ripple’s progress this year.

Last call for Ripple Swell 2025!🔔

Tune into our final keynote from NYC as @bgarlinghouse and @scarletfu discuss what's ahead for Ripple, XRP, key trends to watch in 2026 and why we're doubling down on crypto infrastructure for financial utility.

starts in 30 mins ⬇️ pic.twitter.com/NO3u0k3NeJ

— Ripple (@Ripple) November 5, 2025

This includes a $500 million funding round at a $40 billion valuation, along with major partnerships and acquisitions. Ripple also announced new products, including a prime brokerage service designed to enhance crypto liquidity and institutional access.

Garlinghouse said that Ripple is planning to double down on crypto infrastructure and advocate for clear, global regulations. He expressed strong support for the Crypto Market Structure Bill and the Clarity Act, both expected to shape how digital assets are overseen.

The executive further revealed that Ripple intends to focus on consolidating growth rather than new takeovers in 2026. This comes after a year of four acquisitions, including Palisade Wallet and Custody.

Garlinghouse confirmed that the company has no plans to launch a crypto exchange, instead prioritizing custody, treasury management, and prime brokerage solutions.

XRP Ecosystem Gains Traction

Ripple’s CEO reaffirmed that XRP is the core of its ecosystem, focusing on improving trust, utility, and liquidity. Following legal clarity around the token, funds have been steadily flowing back into XRP.

Garlinghouse predicted that institutional demand could surge once the Crypto Market Structure Bill passes and a spot XRP ETF launches , potentially as early as next week. He compared this expected wave of interest to Ethereum’s rally after its ETF approval.

Meanwhile, Garlinghouse also joined a community discussion on X about whether it’s better to say “on XRP” or “on XRPL.” He agreed that “on XRP” sounds better than the technically correct “on XRPL,” reflecting a deeper connection with the community’s culture.

I agree, on XRP sounds better

— Brad Garlinghouse (@bgarlinghouse) November 5, 2025

Analysts anticipate further upside for XRP, with some predicting a new yearly peak before December ends.

The sell wall for $XRP exist at $2.55 pic.twitter.com/aqVpAUBsF3

— CW (@CW8900) November 5, 2025

In the short term, trader CW cautioned that investors should watch for a potential sell wall at $2.55, which could test XRP’s momentum before its next major move.

next
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Voices of doubt arise, Moderna CEO reassures the market: Personalized cancer vaccines will cover more types of cancer

Moderna's CEO is highly confident about the prospects of the personalized mRNA cancer vaccine intismeran autogene, stating that it will play a role in more cancers beyond melanoma and drawing parallels with Merck's blockbuster drug Keytruda. Jefferies warns that cross-indication replication is still inconclusive; Citi maintains a "sell" rating, pointing out that commercial application remains limited, with critical issues such as patient suitability, manufacturing, and overall survival data yet to be addressed.

华尔街见闻•2026/10/27 02:02
Voices of doubt arise, Moderna CEO reassures the market: Personalized cancer vaccines will cover more types of cancer

Morgan Stanley Declares U.S. Stock Market Correction Nears End! Maintains Year-End S&P 8000 Target, Identifies Three Major Rebound Catalysts

As Morgan Stanley remains bullish on the stock market, recent market trends have precisely demonstrated the strong rebound momentum of tech stocks dominated by the semiconductor sector. The Philadelphia Semiconductor Index rose by 0.44% on October 23rd and further increased by 2.82% on the 26th.

智通财经•2026/10/27 01:41
Morgan Stanley Declares U.S. Stock Market Correction Nears End! Maintains Year-End S&P 8000 Target, Identifies Three Major Rebound Catalysts

Eight Highlights of Anthropic IPO Prospectus: Astonishing Growth, but Risks are Obvious

The Anthropic prospectus reveals several highlights: a large-scale enterprise customer base with over 1,900 customers generating more than one million dollars in revenue; as of June 2026, revenue has increased by 1,368% year over year, far surpassing the growth rate of computing costs; positive operating cash flow; and all seven co-founders remain with the company. The company also acknowledges risks, including concentrated supply from TSMC and potential memory chip shortages as significant concerns. October ARR data will be additionally disclosed in a revised version of the document.

华尔街见闻•2026/10/27 01:01
Eight Highlights of Anthropic IPO Prospectus: Astonishing Growth, but Risks are Obvious

Selling Chips, Leasing, Providing Residual Value Support: Broadcom (AVGO.US) Teams Up with Wall Street's Four Giants to Raise $63 Billion to "Inject Funds" for Anthropic's Chip Procurement

Broadcom has reached a $63 billion deal with Bank of America, Blackstone Group, Citigroup, and Morgan Stanley to provide funding for the purchase of chips for AI model developer Anthropic PBC. The transaction is conducted through a newly established special purpose company, which has secured financial commitments from these firms to purchase Broadcom chips and lease them to Anthropic.

智通财经•2026/10/27 01:01
Selling Chips, Leasing, Providing Residual Value Support: Broadcom (AVGO.US) Teams Up with Wall Street's Four Giants to Raise $63 Billion to "Inject Funds" for Anthropic's Chip Procurement